RB1 and non-Hodgkin lymphoma: In vitro studies showed that the “off-rate” of PL-RB was lower than its parental mAbs, which was mainly attributed to the large amount of 11B8s mass-arrayed on the cellular surface and, consequently, the enhanced the affinity of rituximab to the NHL cells47.